CMRX: Chimerix, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 797.33
Enterprise Value ($M) 766.28
Book Value ($M) 121.68
Book Value / Share 1.30
Price / Book 6.55
NCAV ($M) 111.62
NCAV / Share 1.19
Price / NCAV 7.14

Profitability (mra)
Return on Invested Capital (ROIC) -0.72
Return on Assets (ROA) -0.46
Return on Equity (ROE) -0.51

Liquidity (mrq)
Quick Ratio 5.70
Current Ratio 5.70

Balance Sheet (mrq) ($M)
Current Assets 135.95
Assets 146.01
Liabilities 24.33
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.21
Operating Income -96.57
Net Income -88.39
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -74.98
Cash from Investing 71.32
Cash from Financing 7.05

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-02 83,772 1,282,896 6.53
2025-04-01 177,587 1,653,963 10.74
2025-03-31 545,772 1,754,280 31.11
2025-03-28 142,116 743,004 19.13

(click for more detail)

Similar Companies
CHRS – Coherus BioSciences, Inc. CLSD – Clearside Biomedical, Inc.
CLYM – Climb Bio, Inc. CRMD – CorMedix Inc.
CRON – Cronos Group Inc.


Financial data and stock pages provided by
Fintel.io